相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amine modification of calcium phosphate by low-pressure plasma for bone regeneration
Joe Kodama et al.
SCIENTIFIC REPORTS (2021)
Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review
Yabing Hua et al.
DRUG DELIVERY (2021)
A xenograft model to evaluate the bone forming effects of sclerostin antibody in human bone derived from pediatric osteogenesis imperfecta patients
Rachel K. Surowiec et al.
BONE (2020)
Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review
Yuichiro Ukon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease
Takahiro Makino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Prostaglandin E2 Modulates Bone Morphogenetic Protein-2 Induced Osteogenic Differentiation on a Biomimetic 3D Nanofibrous Scaffold
Yangxi Liu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)
Osteogenesis and aging: lessons from mesenchymal stem cells
Arantza Infante et al.
STEM CELL RESEARCH & THERAPY (2018)
Osteoinduction of bone grafting materials for bone repair and regeneration
Elena Garcia-Gareta et al.
BONE (2015)
Novel EP4 Receptor Agonist-Bisphosphonate Conjugate Drug (C1) Promotes Bone Formation and Improves Vertebral Mechanical Properties in the Ovariectomized Rat Model of Postmenopausal Bone Loss
Careesa C. Liu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The Prostanoid EP4 Receptor and Its Signaling Pathway
Utako Yokoyama et al.
PHARMACOLOGICAL REVIEWS (2013)
Bone regeneration: current concepts and future directions
Rozalia Dimitriou et al.
BMC MEDICINE (2011)
Ectopic study of tissue-engineered bone complex with enamel matrix proteins, bone marrow stromal cells in porous calcium phosphate cement scaffolds, in nude mice
X. J. Wang et al.
CELL PROLIFERATION (2011)
EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures
Tomoko Minamizaki et al.
BONE (2009)
In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents
M. E. Downey et al.
BONE (2009)
Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation
Keisuke Nakagawa et al.
BONE (2007)
A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats
U. T. Iwaniec et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats
Masako Ito et al.
BONE (2006)
A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats
HZ Ke et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist
H Toyoda et al.
BONE (2005)
Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats
M Tanaka et al.
BONE (2004)
Functional pharmacology of human prostanoid EP2 and EP4 receptors
RJ Wilson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
分享论文
